Barely Significant
← all excerpts

Trifarotene: A Current Review and Perspectives in Dermatology.

Biomedicines · 2021 · PMC7996910 · PMID 33652835

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
In both studies, at week 12, primary and secondary endpoints were reached and the results were highly significant ( p < 0.001) in favour of trifarotene, demonstrating its safety, efficacy, and tolerability in acne treatment of both face and trunk [ 36 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.